$218.87
0.06% yesterday
NYSE, Jun 27, 10:10 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$218.87
+7.85 3.72% 1M
-114.35 34.32% 6M
-108.69 33.18% YTD
-109.89 33.43% 1Y
-85.95 28.20% 3Y
-1.26 0.57% 5Y
+160.98 278.08% 10Y
+204.87 1,463.36% 20Y
NYSE, Closing price Fri, Jun 27 2025
-0.13 0.06%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Basic
Market capitalization
$15.7b
Enterprise Value
$15.5b
Net debt
$-197.4m
Cash
$404.2m
Shares outstanding
71.8m
Valuation (TTM | estimate)
P/E
34.20 | 34.43
P/S
5.43 | 5.26
EV/Sales
5.36 | 5.19
EV/FCF
50.59
P/B
5.86
Dividends
DPS
$0.82
Yield 1Y | 5Y
0.37% | 0.23%
Growth 1Y | 5Y
5.13% | 5.75%
Payout 1Y | 3Y
12.26% | 10.50%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$2.9b | $3.0b
EBITDA
$745.0m | $722.8m
EBIT
$585.2m
Net Income
$467.2m | $456.5m
Free Cash Flow
$306.9m
Growth (TTM | estimate)
Revenue
-1.12% | 3.38%
EBITDA
-7.21% | -2.97%
EBIT
-11.55%
Net Income
-17.85% | -7.35%
Free Cash Flow
-20.51%
Margin (TTM | estimate)
Gross
34.54%
EBITDA
25.73% | 24.17%
EBIT
20.21%
Net
16.13% | 15.26%
Free Cash Flow
10.60%
Financial Health
Equity Ratio
73.62%
Return on Equity
18.37%
ROCE
18.93%
ROIC
16.80%
Debt/Equity
0.08
More
EPS
$6.40
FCF per Share
$4.27
Short interest
3.81%
Employees
10.60k
Rev per Employee
$270.00k
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

14x Buy
78%
4x Hold
22%

Analyst Opinions

18 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
78%
Hold
22%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,896 2,896
1% 1%
100%
- Direct Costs 1,896 1,896
3% 3%
65%
1,000 1,000
8% 8%
35%
- Selling and Administrative Expenses 340 340
4% 4%
12%
- Research and Development Expense 68 68
2% 2%
2%
745 745
7% 7%
26%
- Depreciation and Amortization 160 160
13% 13%
6%
EBIT (Operating Income) EBIT 585 585
12% 12%
20%
Net Profit 467 467
18% 18%
16%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Neutral
Business Wire
about 7 hours ago
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containment solutions, and deli...
Neutral
GlobeNewsWire
about 9 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West  between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-42...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today